Navigating the mental health impact of GLP-1s, with Rachel Goldman, PhD
Over the past several years, the rise of GLP-1 drugs such as Ozempic and Wegovy has changed the conversation around weight and obesity in the U.S. Rachel Goldman, PhD, talks about how GLP-1s work; the effects they can have on mental health; what questions to ask if you’re considering trying these medications; how…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from Speaking of Psychology
See all episodes →
48%AI “de-skilling”: What happens when we offload our work to AI? With Brooke Macnamara, PhD
38%Why people cheat—and can relationships recover, with Galena Rhoades, PhD
36%The Science of Suicide Prevention, with Matthew Nock, PhD
Similar episodes from other shows
More like Speaking of Psychology →
GLP-1s & eating disorders: a complicated relationship
Thoughts on Ozempic from a body-positive doctor
The Scale is LYING to You (& Destroying Your Self-Worth) with Dr. Rachel Goldman
The GLP 1 Revolution: The Science of Weight Without Shame with Dr. Alexandra Sowa
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.